Discovery of diarylacrylonitriles as a novel series of small molecule sortase A inhibitors.
On the basis of a hit from random screening, a novel class of small-molecule sortase A inhibitors was generated. The primary structure-activity relationship and the minimal structural requirements for potency were established through structural modifications and molecular modeling studies.